Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and leucine

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with leucine in 3 studies

Compound Research Comparison

Studies
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Trials
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Recent Studies (post-2010)
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Studies
(leucine)
Trials
(leucine)
Recent Studies (post-2010) (leucine)
31156428,5157444,178

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardaillou, R; Chansel, D; Czekalski, S; Ronco, P; Vandermeersch, S1
Li, Q; Pfaffendorf, M; van Zwieten, PA1
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S1

Other Studies

3 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and leucine

ArticleYear
Evidence for angiotensin IV receptors in human collecting duct cells.
    Kidney international, 1996, Volume: 50, Issue:4

    Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Biphenyl Compounds; Blotting, Northern; Calcium; CD13 Antigens; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Imidazoles; Kidney Tubules, Collecting; Leucine; Losartan; Pyridines; Receptors, Angiotensin; RNA, Messenger; Tetrazoles

1996
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2

    Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents

2001
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
    Journal of neurochemistry, 2003, Volume: 86, Issue:2

    Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity

2003